• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Anti ‐Inflammatory Therapy for Atherosclerosis:Interpreting Divergent Results from the CANTOS and CIRT Clinical Trials
This article is protected by copyright. All rights reserved.
Source: Journal of Internal Medicine - November 25, 2018 Category: Internal Medicine Authors: Paul M Ridker Tags: Commentary Source Type: research

Morbidity and cause ‐specific mortality in first‐time myocardial infarction with nonobstructive coronary arteries
ConclusionsPatients with first ‐time MINOCA have a considerable risk of adverse events. This stresses the need for a comprehensive search of the cause of MINOCA, thorough treatment of underlying disease triggers and close follow‐up.
Source: Journal of Internal Medicine - November 25, 2018 Category: Internal Medicine Authors: K. M. Eggers, M. Hjort, T. Baron, T. Jernberg, A. M. Nordenskj öld, P. Tornvall, B. Lindahl Tags: Original Article Source Type: research

CCL23 is a promising biomarker of injury in patients with ischaemic stroke
Journal of Internal Medicine, EarlyView.
Source: Journal of Internal Medicine - March 5, 2018 Category: Internal Medicine Source Type: research

Management of acute ischaemic stroke in patients with dementia
Source: Journal of Internal Medicine - February 20, 2018 Category: Internal Medicine Tags: Corrigendum Source Type: research

CCL23: A new CC chemokine involved in human brain damage
ConclusionsDespite pre‐clinical models do not seem suitable to characterize CCL23, it might be a novel promising biomarker for the early diagnosis of cerebral lesions and might facilitate the prediction of stroke patient outcome.This article is protected by copyright. All rights reserved.
Source: Journal of Internal Medicine - February 7, 2018 Category: Internal Medicine Authors: Alba Simats, Teresa Garc ía‐Berrocoso, Anna Penalba, Dolors Giralt, Gemma Llovera, Yinghua Jiang, Laura Ramiro, Alejandro Bustamante, Elena Martinez‐Saez, Francesc Canals, Xiaoying Wang, Arthur Liesz, Anna Rosell, Joan Montaner Tags: Original Article Source Type: research

CCL23 is a promising biomarker of injury in patients with ischemic stroke
This article is protected by copyright. All rights reserved.
Source: Journal of Internal Medicine - February 1, 2018 Category: Internal Medicine Authors: Aldo Bonaventura, Fabrizio Montecucco Tags: Editorial Comment Source Type: research

Proton ‐Pump Inhibitor use and the risk of Ischaemic Stroke
Click here to view the Letter to the Editor by Dr. Sehested et al.
Source: Journal of Internal Medicine - November 26, 2017 Category: Internal Medicine Authors: C. Dai, M. Jiang, Q. Cao Tags: Letter to the Editor Source Type: research

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE ‐LY trial
ConclusionsAmongst the current clinical bleeding risk scores, the ORBIT score demonstrated the best discrimination and calibration. All the scores demonstrated, to a variable extent, an interaction with bleeding risk associated with dabigatran or warfarin.
Source: Journal of Internal Medicine - November 7, 2017 Category: Internal Medicine Authors: M. Proietti, Z. Hijazi, U. Andersson, S. J. Connolly, J. W. Eikelboom, M. D. Ezekowitz, D. A. Lane, J. Oldgren, V. Roldan, S. Yusuf, L. Wallentin, Tags: Original Article Source Type: research

Long ‐term use of proton pump inhibitors, dose–response relationship and associated risk of ischemic stroke and myocardial infarction
ConclusionUse of PPIs was associated with increased risks of first‐time ischemic stroke and MI, particularly amongst long‐term users and at high doses.
Source: Journal of Internal Medicine - November 7, 2017 Category: Internal Medicine Authors: T. S. G. Sehested, T. A. Gerds, E. L. Fosb øl, P. W. Hansen, M. G. Charlot, N. Carlson, M. A. Hlatky, C. Torp‐Pedersen, G. H. Gislason Tags: Original Article Source Type: research

Reply: Proton ‐Pump Inhibitor Use and the Risk of First‐Time Ischemic Stroke in the General Population
This article is protected by copyright. All rights reserved.
Source: Journal of Internal Medicine - November 1, 2017 Category: Internal Medicine Authors: Thomas S. G. Sehested, Mark A. Hlatky, Nicholas Carlson, Gunnar H. Gislason Tags: Letter to the Editor Source Type: research

Proton ‐Pump Inhibitor Use and the Risk of First‐Time Ischemic Stroke in the General Population
This article is protected by copyright. All rights reserved.
Source: Journal of Internal Medicine - October 28, 2017 Category: Internal Medicine Authors: Cong Dai, Min Jiang, Qin Cao Tags: Letter to the Editor Source Type: research

Comparison of Bleeding Risk Scores in Patients with Atrial Fibrillation:Insights from the RE ‐LY Trial
ConclusionsAmong the current clinical bleeding risk scores, the ORBIT score demonstrated the best discrimination and calibration. All the scores demonstrated, to a variable extent, an interaction with bleeding risk associated with dabigatran or warfarin.This article is protected by copyright. All rights reserved.
Source: Journal of Internal Medicine - October 16, 2017 Category: Internal Medicine Authors: Marco Proietti, Ziad Hijazi, Ulrika Andersson, Stuart J Connolly, John W Eikelboom, Michael D Ezekowitz, Deirdre A. Lane, Jonas Oldgren, Vanessa Roldan, Salim Yusuf, Lars Wallentin, Tags: Original Source Type: research

Long ‐term use of Proton Pump Inhibitors, Dose‐response Relationship, and Associated Risk of Ischemic Stroke and Myocardial Infarction
ConclusionUse of PPIs was associated with increased risks of first‐time ischemic stroke and MI, particularly among long‐term users and at high doses.This article is protected by copyright. All rights reserved.
Source: Journal of Internal Medicine - October 1, 2017 Category: Internal Medicine Authors: Thomas S. G. Sehested, Thomas A. Gerds, Emil L. Fosb øl, Peter W. Hansen, Mette G. Charlot, Nicholas Carlson, Mark A. Hlatky, Christian Torp‐Pedersen, Gunnar H. Gislason Tags: Original Source Type: research

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease
ConclusionsPsychosocial stress, such as depressive symptoms, loss of interest, living alone, and financial stress, was associated with increased CV mortality in patients with stable CHD despite optimal medical secondary prevention treatment. Secondary prevention of CHD should therefore focus also on psychosocial issues both in clinical management and in future clinical trials.This article is protected by copyright. All rights reserved.
Source: Journal of Internal Medicine - September 28, 2017 Category: Internal Medicine Authors: Emil Hagstr öm, Fredrika Norlund, Amanda Stebbins, Paul W Armstrong, Karen Chiswell, Christopher B Granger, José López‐Sendón, Daniel Pella, Joseph Soffer, Rody Sy, Lars Wallentin, Harvey D White, Ralph A H Stewart, Claes Held, Tags: Original Source Type: research

Pages: 1  2  3  4  5